The FDA has issued a warning about counterfeit semaglutide (Ozempic) products in the US drug supply, specifically those labelled with lot number NAR0074 and serial number 430834149057. The agency is investigating thousands of units of the 1-mg injection product and has confirmed that the pen needles, labels, and packaging are fake, posing a potential infection risk. Patients should only obtain Ozempic with a valid prescription from licensed pharmacies and check for signs of counterfeiting. There have been at least five adverse events reported from the counterfeit lot. The FDA is working with the manufacturer to remove further suspected counterfeit products. Counterfeit products should be reported to the FDA.
Source link
FDA Issues Warning About Counterfeit Ozempic
